1. Analysis of the Role of Plasma 25‐Hydroxyvitamin D Levels in Survival Outcomes in Patients from the Phase III MPACT Trial of Metastatic Pancreatic Cancer. (11th January 2021) Authors: Von Hoff, Daniel D.; Cridebring, Derek; Tian, Olivia Yu; Han, Haiyong; Bhore, Rafia; Franco, Twyla; Ondovik, Michael S.; Louis, Chrystal U. Journal: Oncologist Issue: Volume 26:Number 4(2021) Page Start: e704 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase II trial of panobinostat, an oral pan‐deacetylase inhibitor in patients with primary myelofibrosis, post–essential thrombocythaemia, and post–polycythaemia vera myelofibrosis. (23rd May 2013) Authors: DeAngelo, Daniel J.; Mesa, Ruben A.; Fiskus, Warren; Tefferi, Ayalew; Paley, Carole; Wadleigh, Martha; Ritchie, Ellen K.; Snyder, David S.; Begna, Kebede; Ganguly, Siddhartha; Ondovik, Michael S.; Rine, Jessica; Bhalla, Kapil N. Journal: British journal of haematology Issue: Volume 162:Number 3(2013:Aug.) Page Start: 326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗